FIA
HSTO

FNY Investment Advisers’s Histogen Inc. Common Stock HSTO Stock Holding History

FNY Investment Advisers’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2
Closed – – 1030
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1139
2018
Q3 		$1K Sell
2
-1
-33% -$921 ﹤0.01% 834
2018
Q2 		$2K Buy
+3
New +$2.49K ﹤0.01% 862

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FNY Investment Advisers's HSTO Position: Q1 2019 in Review

FNY Investment Advisers sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 2 shares.

FNY Investment Advisers first reported a position in HSTO in Q2 2018 and held it in 3 quarters. The position peaked at $2K in Q2 2018. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • FNY Investment Advisers reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 2 Histogen Inc. Common Stock shares in Q1 2019.
  • FNY Investment Advisers first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Histogen Inc. Common Stock position peaked at $2K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.